Imax price target raised to $25 from $24 at Barrington

Barrington raised the firm’s price target on Imax to $25 from $24 and keeps an Outperform rating on the shares, citing improved EBITDA in the quarter. Imax commanded an “impressive” 5.9% of domestic box office in Q1 on 1% of the screens and should continue to generate a high share as the film slate rebounds into 2025 and 2026, the analyst tells investors.